IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024
AggregatedpresentationbydayandbymarketPurchases of own shares from July 8th to 12th 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1108/07/2024FR00102591506 650111,0282XPARIPSEN549300M6SGDPB4Z94P11...
Comunicato Precedente
Comunicato Successivo
Boulogne Billancourt,
(informazione.it - comunicati stampa - salute e benessere)
![](https://www.globenewswire.com/newsroom/ti?nf=MTAwMDk3MTczMiM0MDE4OTU4NjMjMjI1NjU2Nw==)
Aggregatedpresentationbydayandbymarket
Purchases of own shares from July 8th to 12th 2024 | ||||||
Name of the Issuer | Identity code of the Issuer | Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 6 650 | 111,0282 | XPAR |
IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 2 700 | 110,9397 | CEUX |
IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 350 | 111,1231 | TQEX |
IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 300 | 111,2180 | AQEU |
IPSEN | 549300M6SGDPB4Z94P11 | 09/07/2024 | FR0010259150 | 4 900 | 109,7478 | XPAR |
IPSEN | 549300M6SGDPB4Z94P11 | 09/07/2024 | FR0010259150 | 2 100 | 109,6744 | CEUX |
IPSEN | 549300M6SGDPB4Z94P11 | 10/07/2024 | FR0010259150 | 5 382 | 108,6341 | XPAR |
IPSEN | 549300M6SGDPB4Z94P11 | 10/07/2024 | FR0010259150 | 2 000 | 108,7151 | CEUX |
IPSEN | 549300M6SGDPB4Z94P11 | 11/07/2024 | FR0010259150 | 1 487 | 110,1258 | XPAR |
IPSEN | 549300M6SGDPB4Z94P11 | 11/07/2024 | FR0010259150 | 299 | 110,1107 | CEUX |
TOTAL | 26 168 | 109,9431 |
Attachment
![](https://ml-eu.globenewswire.com/media/NjQ1YzcwNmMtNWU3NS00NzVhLTgwNDAtMjFmZWJjMmJjYWExLTEyNjgxMTY=/tiny/Ipsen-Pharma.png)
Per maggiori informazioni
Sito Web
https://www.ipsen.com/
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti